Regulation of the common carotid arterial blood flow by nicotinic receptors in the medulla of cats

被引:12
作者
Gong, C-L
Chiu, Y-T
Lin, N-N
Cheng, C-C
Lin, S-Z
Lee, T. J-F
Kuo, J-S
机构
[1] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien 970, Taiwan
[2] Buddhist Tzu Chi Gen Hosp, Neuromed Sci Ctr, Hualien, Taiwan
[3] Buddhist Tzu Chi Gen Hosp, Ctr Vasc Med, Hualien, Taiwan
[4] China Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan
[5] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan
[6] Natl Chung Hsing Univ, Dept Vet Med, Taichung, Taiwan
[7] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan
[8] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA
关键词
cholinergic receptor; carotid artery; medulla; nAChR; parasympathetic; vascular regulation;
D O I
10.1038/sj.bjp.0706844
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Actions of glutamate and serotonin on their respective receptors in the dorsal facial area (DFA) of the medulla are known to regulate common carotid arterial (CCA) blood flow in cats. Less is known about acetylcholine action on its nicotinic receptor (nAChR) subtypes in the DFA for regulation of CCA blood flow and this aspect was investigated. Experimental approach: Nicotinic and muscarinic agonists and antagonists were microinjected into the DFA through a three-barrel tubing in anesthetized cats. Results: CCA blood flow was dose-dependently increased by nicotine (a non-selective nAChR agonist) and choline (a selective alpha 7-nAChR agonist). These effects of nicotine were attenuated by alpha-bungarotoxin (an alpha 7-nAChR antagonist), methyllycaconitine (an alpha 7-nAChR antagonist), mecamylamine (a relatively selective alpha 3 beta 4-nAChR antagonist) and dihydro-beta-erythroidine (a relatively selective alpha 4 beta 2-nAChR antagonist). The choline-induced flow increase was attenuated by alpha-bungarotoxin and mecamylamine, but not by dihydro-beta-erythroidine. Muscarinic agonists (muscarine and methacholine) and antagonist (atropine) affected neither the basal nor the nicotine-induced increase in the CCA blood flow. Conclusions and implications: Functional alpha 7, alpha 4 beta 2, and alpha 3 beta 4 subunits of the nAChR appear to be present on the DFA neurons. Activations of these receptors increase the CCA blood flow. The present findings do not preclude the presence of other nAChRs subunits. Muscarinic receptors, if any, on the DFA are not involved in regulation of the CCA blood flow. Various subtypes of nAChRs in the DFA may mediate regulation of the CCA and cerebral blood flows.
引用
收藏
页码:206 / 214
页数:9
相关论文
共 40 条
[1]   Cardiovascular responses to microinjections of nicotine into the caudal ventrolateral medulla of the rat [J].
Aberger, K ;
Chitravanshi, VC ;
Sapru, HN .
BRAIN RESEARCH, 2001, 892 (01) :138-146
[2]  
Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396
[3]   A non-α7 nicotinic acetylcholine receptor modulates excitatory input to hippocampal CA1 interneurons [J].
Alkondon, M ;
Albuquerque, EX .
JOURNAL OF NEUROPHYSIOLOGY, 2002, 87 (03) :1651-1654
[4]   Characterization of nicotinic receptors inducing noradrenaline release and absence of nicotinic autoreceptors in human neocortex [J].
Amtage, F ;
Neughebauer, B ;
McIntosh, JM ;
Freiman, T ;
Zentner, J ;
Feuerstein, TJ ;
Jackisch, R .
BRAIN RESEARCH BULLETIN, 2004, 62 (05) :413-423
[5]   BETA-SUBUNITS CO-DETERMINE THE SENSITIVITY OF RAT NEURONAL NICOTINIC RECEPTORS TO ANTAGONISTS [J].
CACHELIN, AB ;
RUST, G .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1995, 429 (03) :449-451
[6]   Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus [J].
Cao, YJ ;
Surowy, CS ;
Puttfarcken, PS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03) :1298-1304
[7]  
ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346
[8]  
Chyi T, 2005, CHINESE J PHYSIOL, V48, P31
[9]   VASODILATATION PRODUCED BY STIMULATION OF PARVOCELLULAR RETICULAR-FORMATION IN THE MEDULLA OF ANESTHETIZED-DECEREBRATE CATS [J].
CHYI, T ;
CHENG, V ;
CHAI, CY ;
KUO, JS .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1995, 56 (1-2) :69-74
[10]  
Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1